X0201 42004-01-06 0000921768 BANKATLANTIC BANCORP INC BBX 0001199942 GINESTRA MARY E 1750 E. SUNRISE BLVD. FT. LAUDERDALE FL 33304 1000Options to Buy Class A Common Stock 7.41032004-01-064A015310A2013-03-31Class A Common Stock15316531IGinestra TrustOptions to Buy Class A Common Stock8.55852004-01-064A015310A2012-03-04Class A Common Stock15316531IGinestra Trust Options to Buy Class A Common Stock 2.96642004-01-064A015310A2011-01-02Class A Common Stock15316531IGinestra Trust Options to Buy Class A Common Stock 2.82322004-01-064A015310A2010-05-02Class A Common Stock15316531IGinestra Trust Options to Buy Class A Common Stock4.74292004-01-064A017610A2009-04-06Class A Common Stock17617511IGinestra Trust Options to Buy Class A Common Stock 9.3612004-01-064A017610A2008-04-15Class A Common Stock17617511IGinestra Trust Options to Buy Class A Common Stock 5.08572004-01-064A043000A2007-05-01Class A Common Stock430018340IGinestra Trust Options to Buy Class A Common Stock 4.15812004-01-064A043000A2006-05-22Class A Common Stock430018340IGinestra Trust The exercise price of these previously granted and reported stock options was adjusted from $9.68 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).Reflects an adjustment in the number of shares issuable under previously granted and reported stock options by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).Options are currently exercisable.Trust f/b/o Mary E. Ginestra under Trust Agreement dated December 4, 1998, Mary E. Ginestra, Trustee.The exercise price of these previously granted and reported stock options was adjusted from $11.18 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).The exercise price of these previously granted and reported stock options was adjusted from $3.875 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).The exercise price of these previously granted and reported stock options was adjusted from $3.688 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).The exercise price of these previously granted and reported stock options was adjusted from $6.1957 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).The exercise price of these previously granted and reported stock options was adjusted from $12.2283 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).The exercise price of these previously granted and reported stock options was adjusted from $6.6435 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).The exercise price of these previously granted and reported stock options was adjusted from $5.4317 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).Mary E. Ginestra2004-01-06